Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study von Cohen, Ezra E W, Soulières, Denis, Le Tourneau, Christophe, Dinis, José, Licitra, Lisa, Ahn, Myung-Ju, Soria, Ainara, Mach, Nicolas, Mehra, Ranee, Burtness, Barbara, Zhang, Pingye, Cheng, Jonathan, Swaby, Ramona F, Acosta-Rivera, Mirelis, Adkins, Douglas R., Aghmesheh, Morteza, Ahn, Myung-Ju, Airoldi, Mario, Aleknavicius, Eduardas, Al-Farhat, Yousuf, Algazi, Alain P., Almokadem, Salah, Alyasova, Anna, Bauman, Jessica R., Benasso, Marco, Berrocal, Alfonso, Bray, Victoria, Burtness, Barbara Ann, Caponigro, Francesco, Castro, Ana, Cescon, Terrence P., Chan, Kelvin, Chaudhry, Arvind, Chauffert, Bruno, Cohen, Ezra, De Boer, J.P., Dietz, Andreas, Dinis, Jose, Dupuis, Charlotte, Digue, Laurence, Escobar Alvarez, Yolanda, Evans, Mererid, Fidler, Mary Jo, Forster, Martin David, Friesland, Signe, Ganti, Apar K., Geoffrois, Lionnel, Grant, Cliona, Gruenwald, Viktor, Harrington, Kevin, Horvai, Geza, Inciura, Arturas, Jang, Raymond, Jankowska, Petra, Jimeno, Antonio, Joseph, Mano, Juarez Ramiro, Alejandro, Karaszewska, Boguslawa, Kawecki, Andrzej, Keilholz, Ulrich, Keller, Ulrich, Kocsis, Judit, Kotecki, Nuria, Kozloff, Mark F., Lambea, Julio, Landherr, Laszlo, Lantsukhay, Yuri, Lazarev, Sergey Alexandrovich, Lee, Lip Way, Le Tourneau, Christophe, Licitra, Lisa, Martincic, Danko, Matorin, Oleg Vladmirovhich, McGrath, Margaret, Machiels, Jean-Pascal, Mehra, Ranee, Misiukiewicz, Krzysztof, Morris, John C., Mufazalov, Fagim Fanisovich, Niu, Jiaxin, Pamoorthy Srinivasan, Devraj, Perez Segura, Pedro, Rauch, Daniel, Ribeiro, Maria Leonor, Rodriguez, Cristina, Rolland, Frederic, Russo, Antonio, Ruzsa, Agnes, Sanches, Frederico, Shin, Sang-Won, Shtiveland, Mikhail, Soulieres, Denis, Specenier, Pol, van Herpen, Carla M.L., Velez-Cortes, Hector A., Walsh, William V., Winterhalder, Ralph, Wojtukiewicz, Marek, Wong, Deborah, Zandberg, Dan

Volltext

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial von Brose, Marcia S, Dr, Nutting, Christopher M, Prof, Jarzab, Barbara, Prof, Elisei, Rossella, Prof, Siena, Salvatore, MD, Bastholt, Lars, MD, de la Fouchardiere, Christelle, MD, Pacini, Furio, Prof, Paschke, Ralf, Prof, Shong, Young Kee, Prof, Sherman, Steven I, Prof, Smit, Johannes W A, Prof, Chung, John, MD, Kappeler, Christian, PhD, Peña, Carol, PhD, Molnár, István, MD, Schlumberger, Martin J, Prof

Volltext

Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer von Hadoux, Julien, Elisei, Rossella, Brose, Marcia S., Hoff, Ana O., Robinson, Bruce G., Gao, Ming, Jarzab, Barbara, Isaev, Pavel, Kopeckova, Katerina, Wadsley, Jonathan, Führer, Dagmar, Keam, Bhumsuk, Bardet, Stéphane, Sherman, Eric J., Tahara, Makoto, Hu, Mimi I., Singh, Ravinder, Lin, Yan, Soldatenkova, Victoria, Wright, Jennifer, Lin, Boris, Maeda, Patricia, Capdevila, Jaume, Wirth, Lori J.

Volltext

Reduced Intensity Allografts for Acute Myeloid Leukemia: Defining the Role of Conditioning and Donor Alloreactivity von Devine, Steven M., Hallemeier, Chris, Fenske, Timothy, Vij, Ravi, DiPersio, John F., Adkins, Douglas A.

Volltext

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742) von Ma, Brigette B Y, Lim, Wan-Teck, Goh, Boon-Cher, Hui, Edwin P, Lo, Kwok-Wai, Pettinger, Adam, Foster, Nathan R, Riess, Jonathan W, Agulnik, Mark, Chang, Alex Y C, Chopra, Akhil, Kish, Julie A, Chung, Christine H, Adkins, Douglas R, Cullen, Kevin J, Gitlitz, Barbara J, Lim, Dean W, To, Ka-Fai, Chan, K C Allen, Lo, Y M Dennis, King, Ann D, Erlichman, Charles, Yin, Jun, Costello, Brian A, Chan, Anthony T C

Volltext

Clinical trial data of Anti–PD-1/PD-L1 therapy for recurrent or metastatic nasopharyngeal Carcinoma: A review von Adkins, Douglas R., Haddad, Robert I.

Volltext

Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial von Adkins, Douglas, Prof, Ley, Jessica, BS, Neupane, Prakash, MD, Worden, Francis, Prof, Sacco, Assuntina G, MD, Palka, Kevin, MD, Grilley-Olson, Juneko E, MD, Maggiore, Ronald, MD, Salama, Noha N, PhD, Trinkaus, Kathryn, PhD, Van Tine, Brian A, MD, Steuer, Conor E, MD, Saba, Nabil F, Prof, Oppelt, Peter, MD

Volltext

Mex3a Marks a Slowly Dividing Subpopulation of Lgr5+ Intestinal Stem Cells von Barriga, Francisco M., Montagni, Elisa, Mana, Miyeko, Mendez-Lago, Maria, Hernando-Momblona, Xavier, Sevillano, Marta, Guillaumet-Adkins, Amy, Rodriguez-Esteban, Gustavo, Buczacki, Simon J.A., Gut, Marta, Heyn, Holger, Winton, Douglas J., Yilmaz, Omer H., Attolini, Camille Stephan-Otto, Gut, Ivo, Batlle, Eduard

Volltext

Genome-Wide Association Study of Suicide Death and Polygenic Prediction of Clinical Antecedents von Docherty, Anna R, Shabalin, Andrey A, DiBlasi, Emily, Monson, Eric, Mullins, Niamh, Adkins, Daniel E, Bacanu, Silviu-Alin, Bakian, Amanda V, Crowell, Sheila, Chen, Danli, Darlington, Todd M, Callor, William B, Christensen, Erik D, Gray, Douglas, Keeshin, Brooks, Klein, Michael, Anderson, John S, Jerominski, Leslie, Hayward, Caroline, Porteous, David J, McIntosh, Andrew, Li, Qingqin, Coon, Hilary

Volltext

Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinoma von Hanna, Glenn J., Adkins, Douglas R., Zolkind, Paul, Uppaluri, Ravindra

Volltext

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial von Uppaluri, Ravindra, Campbell, Katie M, Egloff, Ann Marie, Zolkind, Paul, Skidmore, Zachary L, Nussenbaum, Brian, Paniello, Randal C, Rich, Jason T, Jackson, Ryan, Pipkorn, Patrik, Michel, Loren S, Ley, Jessica, Oppelt, Peter, Dunn, Gavin P, Barnell, Erica K, Spies, Nicholas C, Lin, Tianxiang, Li, Tiantian, Mulder, David T, Hanna, Youstina, Cirlan, Iulia, Pugh, Trevor J, Mudianto, Tenny, Riley, Rachel, Zhou, Liye, Jo, Vickie Y, Stachler, Matthew D, Hanna, Glenn J, Kass, Jason, Haddad, Robert, Schoenfeld, Jonathan D, Gjini, Evisa, Lako, Ana, Thorstad, Wade, Gay, Hiram A, Daly, Mackenzie, Rodig, Scott J, Hagemann, Ian S, Kallogjeri, Dorina, Piccirillo, Jay F, Chernock, Rebecca D, Griffith, Malachi, Griffith, Obi L, Adkins, Douglas R

Volltext

Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma von Robinson, Anthony M., Rathore, Richa, Redlich, Nathan J., Adkins, Douglas R., VanArsdale, Todd, Van Tine, Brian A., Michel, Loren S.

Volltext

Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial von Tap, William D, Dr, Jones, Robin L, MD, Van Tine, Brian A, MD, Chmielowski, Bartosz, MD, Elias, Anthony D, Prof, Adkins, Douglas, Prof, Agulnik, Mark, MD, Cooney, Matthew M, MD, Livingston, Michael B, MD, Pennock, Gregory, MD, Hameed, Meera R, MD, Shah, Gaurav D, MD, Qin, Amy, PhD, Shahir, Ashwin, MD, Cronier, Damien M, PhD, Ilaria, Robert, MD, Conti, Ilaria, MD, Cosaert, Jan, MD, Schwartz, Gary K, Prof

Volltext

Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (P... von Haddad, Robert, Dr, O'Neill, Anne, MS, Rabinowits, Guilherme, MD, Tishler, Roy, MD, Khuri, Fadlo, Prof, Adkins, Douglas, MD, Clark, Joseph, Prof, Sarlis, Nicholas, MD, Lorch, Jochen, MD, Beitler, Jonathan J, Prof, Limaye, Sewanti, MD, Riley, Sarah, MD, Posner, Marshall, Prof

Volltext

Whole genome comparisons of Staphylococcus agnetis isolates from cattle and chickens von Shwani, Abdulkarim, Adkins, Pamela R F, Ekesi, Nnamdi S, Alrubaye, Adnan, Calcutt, Michael J, Middleton, John R, Rhoads, Douglas D

Volltext

Ramucirumab in combination with pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma: a single-centre, phase 1/2 trial von Adkins, Douglas, Ley, Jessica C, Liu, Jingxia, Oppelt, Peter

Volltext

Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas von Mudianto, Tenny, Campbell, Katie M, Webb, Jason, Zolkind, Paul, Skidmore, Zachary L, Riley, Rachel, Barnell, Erica K, Ozgenc, Ibrahim, Giri, Tusar, Dunn, Gavin P, Adkins, Douglas R, Griffith, Malachi, Egloff, Ann Marie, Griffith, Obi L, Uppaluri, Ravindra

Volltext

Outcome After Surgery Alone or With Restricted Use of Chemotherapy for Patients With Low-Risk Neuroblastoma: Results of Children's Oncology Group Study P9641 von STROTHER, Douglas R, LONDON, Wendy B, MURRAY, Kevin, LAVEY, Robert S, MATTHAY, Katherine K, CASTLEBERRY, Robert, MARIS, John M, COHN, Susan L, SCHMIDT, Mary Lou, BRODEUR, Garrett M, SHIMADA, Hiroyuki, THORNER, Paul, COLLINS, Margaret H, TAGGE, Edward, ADKINS, Stanton, REYNOLDS, C. Patrick

Volltext

Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma von Chawla, Sant P, Cranmer, Lee D, Van Tine, Brian A, Reed, Damon R, Okuno, Scott H, Butrynski, James E, Adkins, Douglas R, Hendifar, Andrew E, Kroll, Stew, Ganjoo, Kristen N

Volltext

Biomarker and Tumor Responses of Oral Cavity Squamous Cell Carcinoma to Trametinib: A Phase II Neoadjuvant Window-of-Opportunity Clinical Trial von Uppaluri, Ravindra, Winkler, Ashley E, Lin, Tianxiang, Law, Jonathan H, Haughey, Bruce H, Nussenbaum, Brian, Paniello, Randal C, Rich, Jason T, Diaz, Jason A, Michel, Loren P, Wildes, Tanya, Dunn, Gavin P, Zolkind, Paul, Kallogjeri, Dorina, Piccirillo, Jay F, Dehdashti, Farrokh, Siegel, Barry A, Chernock, Rebecca D, Lewis, Jr, James S, Adkins, Douglas R

Volltext